Medpace Holdings Inc Revenue Growth Rates (MEDP), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Medpace Holdings Inc   (NASDAQ: MEDP)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

MEDP's Revenue Growth by Quarter and Year

Medpace Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MEDP Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 707.33
1st Quarter March 706.60
FY 1,413.93

MEDPs Annual Revenue
Medpace Holdings Inc 's Revenue in the fiscal year 2025 $ 2,530.23 millions
Medpace Holdings Inc 's Revenue in the fiscal year 2024 $ 2,109.05 millions
Medpace Holdings Inc 's Revenue in the fiscal year 2023 $ 1,885.84 millions
Medpace Holdings Inc 's Revenue in the fiscal year 2022 $ 1,460.00 millions
Medpace Holdings Inc 's Revenue in the fiscal year 2021 $ 1,142.38 millions




MEDP Revenue second quarter 2026 Y/Y Growth Comment
Medpace Holdings Inc reported Revenue increase of 17.24% year on year in the second quarter 2026, to $ 707.33 millions, this is lower than Medpace Holdings Inc 's recent average Revenue improvement of 32.65%.

Looking into second quarter 2026 results within Medical Laboratories industry 21 other companies have achieved higher Revenue growth. While Medpace Holdings Inc ' s Revenue growth of 17.24% ranks overall at the positon no. 2107 in the second quarter 2026.


MEDP Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 32.03 % 7.66 % 26.47 %
3rd Quarter September - 23.73 % 8.29 % 28.34 %
2nd Quarter June 17.24 % 14.24 % 14.59 % 31.22 %
1st Quarter March 26.5 % 9.3 % 17.73 % 31.16 %
FY   - 19.97 % 11.84 % -

Financial Statements
Medpace Holdings Inc 's second quarter 2026 Revenue $ 707.33 millions MEDP's Income Statement
Medpace Holdings Inc 's second quarter 2025 Revenue $ 603.31 millions Quarterly MEDP's Income Statement


MEDP Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 7.36 % 0.61 % 1.2 %
3rd Quarter September - 9.38 % 0.99 % 6.86 %
2nd Quarter June 0.1 % 8.01 % 3.34 % 6.17 %
1st Quarter March -0.26 % 4.1 % 2.54 % 10.14 %
FY (Year on Year)   - 19.97 % 11.84 % -


Back to MEDP Growth rate Comparisons >> Back to MEDP Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #22
Healthcare Sector #308
Overall #2107

Revenue Y/Y Growth Statistics
High Average Low
189.87 % 32.65 % 7.17 %
(Sep 30 2018)  
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #22
Healthcare Sector #308
Overall #2107
Revenue Y/Y Growth Statistics
High Average Low
189.87 % 32.65 % 7.17 %
(Sep 30 2018)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Medpace Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
44.72 % 2.79 % -100 %
(Mar 31 2018)  


MEDP's II. Quarter Q/Q Revenue Comment
Medpace Holdings Inc achieved in the II. Quarter 2026 below company average Revenue growth of 0.1% quarter on quarter, to $ 707.33 millions.

Within Medical Laboratories industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Medpace Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1654.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #214
Overall #1654
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #214
Overall #1654
Revenue Q/Q Growth Statistics
High Average Low
44.72 % 2.79 % -100 %
(Mar 31 2018)  


MEDP's II. Quarter Q/Q Revenue Comment
Medpace Holdings Inc achieved in the II. Quarter 2026 below company average Revenue growth of 0.1% quarter on quarter, to $ 707.33 millions.

Within Medical Laboratories industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Medpace Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1654.


Medpace Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 2,782.29 $ 2,678.27 $ 2,530.23 $ 2,358.37 $ 2,231.79
Y / Y Revenue Growth (TTM) 24.67 % 24.19 % 19.97 % 13.88 % 9.94 %
Year on Year Revenue Growth Overall Ranking # 1398 # 141 # 293 # 776 # 20
Seqeuential Revenue Change (TTM) 3.88 % 5.85 % 7.29 % 5.67 % 3.49 %
Seq. Revenue Growth (TTM) Overall Ranking # 2107 # 292 # 1755 # 1983 # 127


Cumulative Revenue growth Comment
Although Medpace Holdings Inc 's Annual Revenue growth year on year were below company's average 32.65% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 24.67% year on year, from 24.19% in Mar 31 2026.

In the Healthcare sector 240 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 141 to 1398.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 22
Healthcare Sector # 241
Overall # 1398

Revenue TTM Y/Y Growth Statistics
High Average Low
189.87 %
 32.65 %
7.17 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 308
S&P 500 # 2107
Cumulative Revenue growth Comment
Although Medpace Holdings Inc 's Annual Revenue growth year on year were below company's average 32.65% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 24.67% year on year, from 24.19% in Mar 31 2026.

In the Healthcare sector 240 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 141 to 1398.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 22
Healthcare Sector # 241
Overall # 1398

Revenue TTM Y/Y Growth Statistics
High Average Low
189.87 %
32.65 %
7.17 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 308
S&P 500 # 2107




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MEDP's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Personalis Inc 29.96%$ 29.960 millions
Beone Medicines Ltd 29.69%$ 29.693 millions
Capsovision Inc 29.60%$ 29.598 millions
Intuitive Surgical Inc 29.27%$ 29.272 millions
Xeris Biopharma Holdings Inc 28.74%$ 28.741 millions
Ultragenyx Pharmaceutical Inc 28.53%$ 28.532 millions
Innoviva Inc 28.39%$ 28.391 millions
Electrocore Inc 28.03%$ 28.031 millions
Lightwave Logic Inc 27.91%$ 27.909 millions
American Shared Hospital Services27.15%$ 27.149 millions
Protalix Biotherapeutics inc 27.07%$ 27.066 millions
Alkermes Plc 26.97%$ 26.968 millions
Lucid Diagnostics Inc 26.74%$ 26.741 millions
Lifestance Health Group Inc 26.08%$ 26.076 millions
Ani Pharmaceuticals Inc25.87%$ 25.866 millions
Sight Sciences Inc 25.83%$ 25.830 millions
Grail Inc 25.72%$ 25.723 millions
Fortress Biotech Inc 25.66%$ 25.658 millions
Apyx Medical Corp25.27%$ 25.273 millions
Radnet Inc 24.99%$ 24.986 millions
Precipio inc 24.18%$ 24.178 millions
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions
Axogen inc 23.06%$ 23.065 millions
Vericel Corporation22.48%$ 22.481 millions


About Medpace Holdings Inc Revenue Growth Rates (MEDP), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Medpace Holdings Inc (CIK 1668397).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001668397-26-000025
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Medpace Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.